Geri-Tussin
- Product NDC
- 57896-693
- Requested package NDC
- 57896-693-08
- 11-digit product format
- 578960693
- Labeler code
- 57896
- Product ID
- 57896-693_4744e526-723f-2ff0-e063-6294a90adc2b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Geri-Care Pharmaceuticals, Corp
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-05-01
- Substance
- GUAIFENESIN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Geri-Tussin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310604 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 65545ca3-4e93-4b59-9e17-4742e086e8e7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57896-693-16 | 2021-03-15 | C162847 | 48780-1 | ba0f9c33-3e85-a910-e053-dadaa90a0b85 | GeriCare- Tussin 693 |
| 57896-693-16 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3e85-a910-e053-dadaa90a0b85 | GeriCare- Tussin 693 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57896-693-04 | Geri-Tussin | 118 mL in 1 BOTTLE | LIQUID | 118 | 8 | |
| 57896-693-08 | Geri-Tussin | 237 mL in 1 BOTTLE | LIQUID | 237 | 8 | |
| 57896-693-16 | Geri-Tussin | 473 mL in 1 BOTTLE | LIQUID | 473 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57896-693-04 | ML - Milliliter | 57896-693 | 7f25273f-d1fc-439d-af72-925bd830bb4a | 1 | 2024-07-12 |
| 57896-693-08 | ML - Milliliter | 57896-693 | b5c35bb9-0318-4e23-b8fd-dff274ac9d70 | 1 | 2026-01-08 |
| 57896-693-16 | ML - Milliliter | 57896-693 | 6f03e183-fd4e-458d-b2ab-ebe17daac28b | 1 | 2019-09-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex Severe All in One Sinus | ACETAMINOPHEN, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | 9a106398-6d9d-2146-e053-2995a90a3fdf | 2026-10-02 | Warnings | M012 |
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 4644c4ae-9607-d404-e063-6294a90aca24 | 2026-10-02 | Warnings | M012 |
| VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | 4645336e-40d8-89e6-e063-6294a90a7655 | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464534ee-15f8-3af8-e063-6394a90a3f18 | 2026-10-02 | Warnings | M012 |
| Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464550b3-5970-aca5-e063-6294a90a5954 | 2026-10-02 | Warnings | M012 |
| Vicks Jarabe Cough Congestion | DEXTROMETHORPHAN HBR AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | a0fa86d4-e53b-cbf4-e053-2995a90a1396 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Cough DM plus Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | c48359ee-6e52-841d-e053-2a95a90ae293 | 2026-10-02 | Warnings | M012 |
| NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | ef6df67c-0afa-4825-e053-2995a90aced9 | 2026-10-02 | Warnings | M012 |
| DayQuil and NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fbd53e5f-bc03-75b4-e053-6394a90af028 | 2026-10-02 | Warnings | M012 |
| DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | ef6e8503-d268-291b-e053-2995a90aec8f | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fd03769c-2fd6-1c22-e053-6394a90a12f6 | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04c9ccda-64aa-0cd0-e063-6394a90a32bf | 2026-10-02 | Warnings | M012 |
| VICKS NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04ca1e9c-f297-cbd6-e063-6294a90a3739 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 1b579102-9eac-1b2f-e063-6394a90add0a | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | d3b2ca47-d51e-f69f-e053-2995a90a587e | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil NyQuil SEVERE HONEY COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 25a092c3-a9cb-6314-e063-6294a90a5297 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Procter & Gamble Manufactura S de RL de CV | 424cf178-39cc-b37c-e063-6394a90a990b | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 4535d4fe-9de7-f2c6-e063-6394a90a944a | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 457180c9-87ea-5b52-e063-6294a90a7e9d | 2026-10-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 8 |
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | a307a54c-2861-4027-bec4-da8a984d211e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 57896-693-08 | 57896069308 | 237 mL in 1 BOTTLE (57896-693-08) | 237 ml | 2025-12-01 | No | No | Current |